Loading
NYSETechnologyInformation Technology Services
Latest quote
$1.515
+$0.05 · +3.41%
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Regular session
$1.515
+$0.05 · +3.41%
Regular session · ET · Market data may be delayed.
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Day range
Current $1.515
52-week range
Current $1.515
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
45
Fair Value
Sentiment
66
Bullish
Risk
69
High Risk
Momentum
29
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Day range
Current $1.515
52-week range
Current $1.515
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.46B USD | 2.56B USD | 2.63B USD | 2.66B USD | 1.88B USD |
| Cost of goods sold | 833.6M USD | 869.2M USD | 906.4M USD | 954M USD | 626.1M USD |
| Gross profit | 1.62B USD | 1.69B USD | 1.72B USD | 1.71B USD | 1.25B USD |
| Selling, general, and administrative | 708.6M USD | 727.6M USD | 739.7M USD | 729.9M USD | 643M USD |
| Operating expenses | 1.55B USD | 1.96B USD | 2.46B USD | 5.63B USD | 1.34B USD |
| Interest expense | 265.4M USD | 283.4M USD | 293.7M USD | 270.3M USD | 252.5M USD |
| Depreciation and amortization | 757.2M USD | 727M USD | 708.3M USD | 710.5M USD | 537.8M USD |
| Operating income | 71.5M USD | −275.6M USD | −734.7M USD | −3.93B USD | −87M USD |
| Net income | −201.1M USD | −636.7M USD | −911.2M USD | −3.96B USD | −270.5M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$2.00
32.01% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV23.39M0.08%30.54B USD0.25%$119.06-0.06%
iShares Russell 2000 ETFIWM13.67M0.02%78.56B USD0.19%$275.15-0.92%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV10.88M0.04%26.69B USD0.33%$37.735-0.16%
Vanguard Extended Market ETFVXF10.21M0.01%95.4B USD0.05%$231.55-0.83%
Vanguard Russell 2000 ETFVTWO4.12M0.02%18B USD0.06%$111.12-0.97%
Dimensional - US Targeted Value ETFDFAT3.82M0.01%30B USD0.33%$66.91-0.25%
EA Bridgeway Omni Small-Cap Value ETFBSVO3.49M0.15%2.37B USD0.45%$28.27-0.07%
Schwab Fundamental U.S. Small Company Index ETFFNDA3.48M0.04%8.72B USD0.25%$35.265-0.38%Avantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWODimensional - US Targeted Value ETFDFATEA Bridgeway Omni Small-Cap Value ETFBSVOSchwab Fundamental U.S. Small Company Index ETFFNDAAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
